Inteliphage
PrivateLast Round
Grant
Jan 17, 2023
Total Funding Raised
$16.74M
Company Overview
Inteliphage operates in Healthcare & Life Sciences and is based in Belgium. Its latest recorded funding round was a Grant round in January 2023.
Inteliphage is a biotechnology company developing evidence-driven, personalized phage-based therapies for patients with difficult-to-treat infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inteliphage Comparables
Compare Inteliphage with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fagoterapia LAB | 80% | |
| PhageOne | 80% | |
| Eliava BioPreparations | 79% |
For institutional investors. Book with your work email.
Inteliphage Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 17, 2023 | ||||
| Series A | Jun 1, 2021 |
For institutional investors. Book with your work email.
Inteliphage Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| BioWin | Grant |
| Walloon Region (Belgium) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 17, 2023
Secured $1.94M from the European Innovation Council.
- Jun 1, 2021
$4M round raised
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- expands_facilitiesOct 20, 2026
Since Sep '26, Inteliphage is expanding bacteriophage production capacity at BioPark Charleroi in Belgium by taking over five existing cleanrooms covering 1,200 m² to support its first clinical treatments in European hospitals.
For institutional investors. Book with your work email.
Inteliphage Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inteliphage's valuation, stock price, and market status.
Is Inteliphage a public or private company?
Inteliphage is a private company.
What is the current stock price of Inteliphage?
Inteliphage is a private company, so its shares have no public market price. Caplight tracks Inteliphage's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inteliphage worth (valuation)?
Valuation information for Inteliphage is not publicly available.
Can I buy Inteliphage stock?
Inteliphage shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inteliphage's last funding round?
Inteliphage's most recent funding round was Grant on January 17, 2023.
Who are the main investors in Inteliphage?
Key investors in Inteliphage include European Innovation Council Fund, BioWin, Walloon Region (Belgium).
Will Inteliphage IPO soon?
No public IPO plans have been announced for Inteliphage.
How can I track Inteliphage secondary market activity?
Caplight tracks bids, offers, and trades in Inteliphage's shares on secondary markets.